- Home
- CCG vs CLSD Comparison
CCG vs CLSD Comparison
Compare CCG & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCG
- CLSD
- Stock Information
- Founded
- CCG 2014
- CLSD 2011
- Country
- CCG China
- CLSD United States
- Employees
- CCG N/A
- CLSD N/A
- Industry
- CCG
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- CCG
- CLSD Health Care
- Exchange
- CCG Nasdaq
- CLSD Nasdaq
- Market Cap
- CCG 64.8M
- CLSD 76.6M
- IPO Year
- CCG N/A
- CLSD 2016
- Fundamental
- Price
- CCG $0.76
- CLSD $1.00
- Analyst Decision
- CCG
- CLSD Strong Buy
- Analyst Count
- CCG 0
- CLSD 6
- Target Price
- CCG N/A
- CLSD $5.33
- AVG Volume (30 Days)
- CCG 154.6K
- CLSD 230.0K
- Earning Date
- CCG 11-26-2024
- CLSD 11-12-2024
- Dividend Yield
- CCG N/A
- CLSD N/A
- EPS Growth
- CCG N/A
- CLSD N/A
- EPS
- CCG N/A
- CLSD N/A
- Revenue
- CCG $478,620,143.00
- CLSD $7,703,000.00
- Revenue This Year
- CCG $4.89
- CLSD N/A
- Revenue Next Year
- CCG $2.74
- CLSD $91.87
- P/E Ratio
- CCG N/A
- CLSD N/A
- Revenue Growth
- CCG 4.67
- CLSD 248.39
- 52 Week Low
- CCG $0.56
- CLSD $0.92
- 52 Week High
- CCG $10.00
- CLSD $2.12
- Technical
- Relative Strength Index (RSI)
- CCG 38.55
- CLSD 42.14
- Support Level
- CCG $0.81
- CLSD $0.99
- Resistance Level
- CCG $0.90
- CLSD $1.05
- Average True Range (ATR)
- CCG 0.05
- CLSD 0.05
- MACD
- CCG -0.01
- CLSD 0.00
- Stochastic Oscillator
- CCG 11.49
- CLSD 15.38
About CCG Cheche Group Inc.
Cheche Group Inc is an insurtech company. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, green auto insurance innovations, etc.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.